Trump Announces He’ll Leave Walter Reed Medical Center Monday Night


President Donald Trump will return to the White House Monday evening after spending the weekend being treated for coronavirus at Walter Reed National Military Medical Center, he announced Monday afternoon on Twitter.

The White House medical team had previously said Sunday that the president could be discharged as early as Monday morning. White House chief of staff Mark Meadows clarified on Fox Monday morning that the medical team would reevaluate and make a decision later that afternoon on whether or not Trump could return to the White House.

BETHESDA, MD - OCTOBER 04: In this handout provided by The White House, President Donald Trump participates in a phone call with Vice President Mike Pence, Secretary of State Mike Pompeo, and Chairman of the Joint Chiefs of Staff Gen. Mark Milley in his conference room at Walter Reed National Military Medical Center on October 4, 2020 in Bethesda, Maryland. Chief of Staff Mark Meadows (not pictured) is also present in the room on the call. (Photo by Tia Dufour/The White House via Getty Images)

WASHINGTON, DC – OCTOBER 02: U.S. President Donald Trump leaves the White House for Walter Reed National Military Medical Center on the South Lawn of the White House on October 2, 2020 in Washington, DC. President Donald Trump and First Lady Melania Trump have both tested positive for coronavirus. (Photo by Drew Angerer/Getty Images)

“I will be leaving the great Walter Reed Medical Center today at 6:30 P.M. Feeling really good,” the president tweeted. “Don’t be afraid of Covid. Don’t let it dominate your life. We have developed, under the Trump Administration, some really great drugs & knowledge. I feel better than I did 20 years ago!” (RELATED: White House Press Secretary Kayleigh McEnany Tests Positive For Coronavirus)

Trump had received a variety of treatments over the past three days, as referenced in his announcement. Of note, he received an 8 gram dose of Regeneron’s antibody cocktail — which has not received approval from the Food and Drug Administration — two courses of Gilead Sciences’ Remdesivir, which was granted an Emergency Use Authorization for treating coronavirus by the FDA over the summer, and a steroid commonly prescribed to ease respiratory inflammation.

Trump’s medical team was scheduled to brief reporters just 20 minutes following his announcement.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *